Literature DB >> 22271652

Phenotypic analysis of pneumococcal polysaccharide-specific B cells.

Noor Khaskhely1, Jason Mosakowski, Rebecca S Thompson, Sadik Khuder, S Louise Smithson, M A Julie Westerink.   

Abstract

The phenotype of B cells responsible for the production of anti-pneumococcal polysaccharide Ab has been unclear. Although individuals that respond poorly to the 23-valent pneumococcal polysaccharide (PPS) vaccine, Pneumovax, such as children <2 y, the asplenic, and a subset of common variable immunodeficiency patients, are profoundly deficient or lack IgM memory cells (CD27(+)IgM(+)), they are also deficient in the switched memory (CD27(+)IgM(-)) compartment. Direct characterization of PPS-specific B cells has not been performed. In this study, we labeled PPS14 and PPS23F with fluorescent markers. Fluorescently labeled PPS were used in FACSAria flow cytometry to characterize the phenotype of PPS-specific B cells obtained from 18 young adults pre- and postimmunization with Pneumovax. The labeled PPS were capable of inhibiting binding of Ab to the native PPS. Similarly, the native PPS were able to inhibit binding of PPS-specific B cells in a flow cytometric assay demonstrating specificity and functionality. Phenotypic analysis of unselected B cells, pre- and postimmunization, demonstrated a predominance of naive CD27(-)IgM(+) cells accounting for 61.5% of B cells. Likewise, the PPS-specific B cells obtained preimmunization consisted primarily of naive, CD27(-) B cells, 55.4-63.8%. In contrast, the PPS-specific B cells obtained postimmunization were predominantly IgM memory cells displaying the CD27(+)IgM(+), 54.2% for PPS14 and 66% for PPS23F, significantly higher than both unselected B cells and PPS-specific B cells. There was no significant difference in switched memory B cell populations (CD27(+)IgM(-)) between groups. These results suggest a dominant role of IgM memory cells in the immune response to pneumococcal polysaccharides.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271652      PMCID: PMC3288481          DOI: 10.4049/jimmunol.1102809

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F.

Authors:  Jianhui Zhou; Kathleen R Lottenbach; Stephen J Barenkamp; Alexander H Lucas; Donald C Reason
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands.

Authors:  Goutam Sen; Abdul Q Khan; Quanyi Chen; Clifford M Snapper
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Isolation and characterization of allergen-binding cells from normal and allergic donors.

Authors:  J Irsch; N Hunzelmann; H Tesch; H Merk; E Maggi; A Ruffilli; A Radbruch
Journal:  Immunotechnology       Date:  1995-08

4.  Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.

Authors:  G Vidarsson; S T Sigurdardottir; T Gudnason; S Kjartansson; K G Kristinsson; G Ingolfsdottir; S Jonsson; H Valdimarsson; G Schiffman; R Schneerson; I Jonsdottir
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response.

Authors:  W Timens; A Boes; T Rozeboom-Uiterwijk; S Poppema
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

6.  Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response.

Authors:  Leen Moens; Margareta Wuyts; Isabelle Meyts; Kris De Boeck; Xavier Bossuyt
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

7.  Natural and vaccine-related immunity to Streptococcus pneumoniae.

Authors:  D M Musher; A J Chapman; A Goree; S Jonsson; D Briles; R E Baughn
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

8.  A checkpoint for autoreactivity in human IgM+ memory B cell development.

Authors:  Makoto Tsuiji; Sergey Yurasov; Klara Velinzon; Saskia Thomas; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Exp Med       Date:  2006-01-30       Impact factor: 14.307

9.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

10.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

View more
  22 in total

Review 1.  B-1 lymphocytes in mice and nonhuman primates.

Authors:  Karen M Haas
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

2.  The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells.

Authors:  David J Leggat; Rebecca S Thompson; Noor M Khaskhely; Anita S Iyer; M A Julie Westerink
Journal:  J Infect Dis       Date:  2013-04-01       Impact factor: 5.226

3.  Polysaccharide-specific B cell responses to vaccination in humans.

Authors:  Ruth Mitchell; Dominic F Kelly; Andrew J Pollard; Johannes Trück
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 4.  Human spleen microanatomy: why mice do not suffice.

Authors:  Birte S Steiniger
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

Review 5.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

6.  Quantitative and Functional Antibody Responses to the 13-Valent Conjugate and/or 23-Valent Purified Polysaccharide Vaccine in Aging HIV-Infected Adults.

Authors:  Jennifer A Ohtola; Jessica L Saul-McBeth; Anita S Iyer; David J Leggat; Sadik A Khuder; Noor M Khaskhely; Ma Julie Westerink
Journal:  J AIDS Clin Res       Date:  2016-03-14

7.  Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals.

Authors:  Myroslawa Happe; Devadoss J Samuvel; Jennifer A Ohtola; Jeff E Korte; M A Julie Westerink
Journal:  Vaccine       Date:  2019-02-21       Impact factor: 3.641

8.  Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Authors:  Rama D Yammani; Karen M Haas
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

9.  Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19⁺CD20⁺CD3⁻CD70⁻CD27⁺IgM⁺CD43⁺CD5⁺/⁻.

Authors:  David J Leggat; Noor M Khaskhely; Anita S Iyer; Jason Mosakowski; Rebecca S Thompson; John D Weinandy; M A Julie Westerink
Journal:  Vaccine       Date:  2013-08-01       Impact factor: 3.641

10.  Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.

Authors:  Jennifer A Ohtola; Noor M Khaskhely; Jessica L Saul-Mcbeth; Anita S Iyer; David J Leggat; Sadik A Khuder; M A Julie Westerink
Journal:  Vaccine       Date:  2015-12-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.